Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.45 |
| ▸ | CACNG2 | Q9Y698 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
| ▸ | TYK2 | P29597 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | SULT1A1 | P50225 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14601427 | 0.89 | ALDH1A1 (0.44) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601418 | 0.89 | JAK2 (0.42) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601428 | 0.86 | KDM4E (0.54) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601416 | 0.85 | KDM4E (0.38) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601424 | 0.85 | HPGD (0.40) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601422 | 0.85 | PTGS2 (0.43) | PIK3CDPIK3CAPIK3CBPIK3CGRORC | |
| SCHEMBL14601425 | 0.84 | KDM4E (0.47) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601420 | 0.84 | KDM4E (0.57) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601419 | 0.83 | KDM4E (0.43) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL14601421 | 0.80 | KDM4E (0.39) | HPGDKDM4ESMN1; SMN2TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070004713-A1 | Therapeutic benimidazole compounds | ASTRAZENECA AB (SE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004713-A1 | Therapeutic benimidazole compounds | ASTRAZENECA AB (SE) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004713-A1 | Therapeutic benimidazole compounds | ESR2, ESRRA, ESRRB | GRIA1 115/4885CACNG8 2808/4885CACNG2 2254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.